OncoMatch/Clinical Trials/NCT06237179

Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

Is NCT06237179 recruiting? Yes, currently enrolling (May 2026). This Phase 1/2 trial studies non-drug interventions for prostate cancer.

Phase 1/2RecruitingVirginia Commonwealth UniversityNCT06237179Data as of May 2026

To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak \& 6-minute walk distance \[6MWD\]) among prostate cancer (PC) patients compared to controls receiving healthy living education (HLE) at 12 weeks.

Check if I qualify

Extracted eligibility criteria

Cancer type

Prostate Cancer

Disease stage

Required: Stage II, III, IV

Prior therapy

Must have received: androgen deprivation therapy — current

currently undergoing treatment with ADT (intermittent or prolonged)

Must have received: local curative-intent treatment (prostatectomy, definitive radiation) — completed

completed local curative-intent treatment, including prostatectomy or definitive radiation

Lab requirements

Blood counts

Hemoglobin < 7.0 grams/dL and Platelet count < 10 x 10^9/L excluded

Hemoglobin < 7.0 grams/dL; Platelet count < 10 x 109/L

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

Richmond Veterans Affairs Medical Center · Richmond, Virginia
Virginia Commonwealth University Massey Cancer Center · Richmond, Virginia

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify